Eyesight Associates Revenue and Competitors

Warner Robins, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Eyesight Associates's estimated annual revenue is currently $9.5M per year.(i)
  • Eyesight Associates's estimated revenue per employee is $216,000

Employee Data

  • Eyesight Associates has 44 Employees.(i)
  • Eyesight Associates grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M39-5%N/AN/A
#2
$26.5M9844%N/AN/A
#3
$120.8M3588%N/AN/A
#4
$16M66-6%N/AN/A
#5
$15.8M6510%N/AN/A
#6
$57M1928%N/AN/A
#7
$56.1M189N/AN/AN/A
#8
$46M1550%N/AN/A
#9
$35.4M1310%N/AN/A
#10
$36.5M1352%N/AN/A
Add Company

What Is Eyesight Associates?

Since 1983 Eyesight Associates has been providing the citizens of middle Georgia with innovative quality eye-care. Founded by Dr. Johnny Gayton, MD, the practice now encompasses eight eye-care providers in four office locations. The corporate office and state of the art surgical center are located in Warner Robins, Georgia. Services we offer include: Optometry and Ophthalmology –eye exams to eye surgery

keywords:N/A

N/A

Total Funding

44

Number of Employees

$9.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eyesight Associates News

2022-04-19 - Roman Abramovich Could Be US Sanctions Target as ...

The U.K. has also targeted Abramovich's close associates Eugene Shvidler, ... loss of eyesight and headaches, people close to him said.

2022-04-17 - Kenneth Steven Tilton | News | telluridenews.com

... community of Telluride, neighbors, many friends and business associates. ... who was a skilled painter prior to losing her eyesight.

2022-04-06 - Macular Degeneration Symptoms: Disease Damages Eye Central Vision

... vision loss, it is very devastating,” Khurana, who is a retina specialist at Northern California Retina Vitreous Associates, told TODAY.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M4513%N/A
#2
$5.8M484%N/A
#3
$11.5M51N/AN/A
#4
$14.1M548%N/A
#5
$11M548%N/A